Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

456
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
456
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

313
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
313
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

406
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
406
Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

264
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
264
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

242
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
242
Dosage Regimen: Multiple Oral Dosage01:25

Dosage Regimen: Multiple Oral Dosage

317
Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...
317

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global current systems in the magnetosphere of Mercury.

Nature communications·2026
Same author

Response: Codeine in Breast Milk: Minimal Transfer, Still Risky for Neonates.

Paediatric anaesthesia·2026
Same author

Codeine and Metabolite Concentrations in the Breastfed Neonate.

Paediatric anaesthesia·2026
Same author

Milk Fasting Times and Aspiration in Infants.

Paediatric anaesthesia·2026
Same author

Whole blood transcriptomics reveals sepsis mortality-associated changes in neutrophil degranulation.

American journal of respiratory cell and molecular biology·2026
Same author

Individualising drug therapy in intensive care.

Anaesthesia and intensive care·2026

Related Experiment Video

Updated: Mar 8, 2026

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

16.7K

Why standards are useful for predicting doses.

Nick H G Holford1, Brian J Anderson2

  • 1Department of Pharmacology & Clinical Pharmacology, University of Auckland, New Zealand.

British Journal of Clinical Pharmacology
|February 4, 2017
PubMed
Summary
This summary is machine-generated.

A standard pharmacokinetic modeling approach is effective for describing drug concentrations and offers biological insights. This method aids in comparing studies, error detection, and rationalizing dose predictions across all ages.

More Related Videos

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.8K
Dosimetry for Cell Irradiation using Orthovoltage 40-300 kV X-Ray Facilities
06:51

Dosimetry for Cell Irradiation using Orthovoltage 40-300 kV X-Ray Facilities

Published on: February 20, 2021

5.6K

Related Experiment Videos

Last Updated: Mar 8, 2026

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

16.7K
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.8K
Dosimetry for Cell Irradiation using Orthovoltage 40-300 kV X-Ray Facilities
06:51

Dosimetry for Cell Irradiation using Orthovoltage 40-300 kV X-Ray Facilities

Published on: February 20, 2021

5.6K

Area of Science:

  • Pharmacokinetics and Drug Development
  • Quantitative Pharmacology
  • Pediatric Drug Dosing

Background:

  • Evaluating the utility of standard pharmacokinetic (PK) modeling approaches versus alternative methods.
  • Assessing the role of PK modeling in understanding drug behavior in diverse patient populations.

Discussion:

  • Standard PK modeling is validated as a robust method for describing drug concentrations.
  • This approach offers significant advantages over ad hoc methods, including enhanced biological understanding.
  • The framework supports critical analyses such as inter-study comparisons and error detection.

Key Insights:

  • Standard PK modeling is not flawed and demonstrates comparable or superior utility to ad hoc methods.
  • The approach facilitates rational dose prediction and provides a foundation for biological inference.
  • Consistent dosing strategies across pediatric and adult populations can be developed.

Outlook:

  • Further exploration of standard PK modeling to challenge new hypotheses in drug disposition.
  • Integration of size and maturation principles within standard PK models for refined dosing.
  • Continued application of standardized PK modeling for optimizing therapeutic outcomes in all age groups.